Changeflow GovPing Healthcare FDA Class II Device Recall: GEM Premier 5000 PAK
Urgent Enforcement Removed Final

FDA Class II Device Recall: GEM Premier 5000 PAK

Favicon for changeflow.com FDA: Device Recalls Class II
Filed March 18th, 2026
Detected March 29th, 2026
Email

Summary

The FDA has initiated a Class II device recall for Instrumentation Laboratory's GEM Premier 5000 PAK (Part No. 00055407511) due to Process Control Solution Not Detected (PCSND) errors. The recall affects worldwide distribution, including the US.

What changed

The FDA has classified a recall of the GEM Premier 5000 PAK (Part No. 00055407511) as Class II, indicating that use of or exposure to the affected product may cause temporary or medically reversible adverse health consequences. The recall is due to confirmed customer complaints of increased Process Control Solution Not Detected (PCSND) errors during warm-up, leading to GEM PAK ejection. This issue requires the insertion of a new cartridge.

Healthcare providers and medical device distributors who have distributed or used the affected GEM Premier 5000 PAKs must be aware of this recall. While the document does not specify immediate actions for users, they should consult Instrumentation Laboratory's recall notification for specific instructions regarding product return, replacement, or other remediation steps. The recall affects worldwide distribution, including the US, Argentina, Austria, Australia, Belgium, Bulgaria, Brazil, Belarus, and Switzerland, among others.

What to do next

  1. Review recall notification from Instrumentation Laboratory for specific instructions.
  2. Identify and segregate affected GEM Premier 5000 PAKs.
  3. Follow manufacturer's instructions for product return or replacement.

Source document (simplified)

Instrumentation Laboratory

Device Recalls (Class II)

← All Device Recalls (Class II) Class II Z-1531-2026 · 20260318 · Ongoing

Product

GEM Premier 5000 PAK; Part No. 00055407511.

Reason for Recall

Confirmed customer complaints indicating that GEM PAKs (cartridges) for the GEM Premier 5000 may experience an increased incidence of Process Control Solution Not Detected (PCSND) errors during warm-up, including consecutive occurrences, resulting in GEM PAK ejection and requiring insertion of ...

Distribution

Worldwide distribution - US Nationwide and the countries of Argentina, Austria, Australia, Belgium, Bulgaria, Brazil, Belarus, Switzerland, Canada,...

Source: openFDA Enforcement API

Source

Analysis generated by AI. Source diff and links are from the original.

Classification

Agency
FDA
Filed
March 18th, 2026
Instrument
Enforcement
Legal weight
Binding
Stage
Final
Change scope
Substantive
Document ID
Z-1531-2026

Who this affects

Applies to
Healthcare providers Medical device makers
Industry sector
3345 Medical Device Manufacturing
Activity scope
Device Recalls
Geographic scope
United States US

Taxonomy

Primary area
Medical Devices
Operational domain
Compliance
Topics
Product Safety Quality Control

Get Healthcare alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when FDA: Device Recalls Class II publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.